Home
>
National Drug Code (NDC)
>
Enoxaparin Sodium
Enoxaparin Sodium - 62037-864-20 - (Enoxaparin Sodium)
Drug Information of Enoxaparin Sodium
| Product NDC: | 62037-864 |
| Proprietary Name: | Enoxaparin Sodium |
| Non Proprietary Name: | Enoxaparin Sodium |
| Active Ingredient(s): | 120 mg/.8mL & nbsp; Enoxaparin Sodium |
| Administration Route(s): | SUBCUTANEOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Enoxaparin Sodium
| Product NDC: | 62037-864 |
| Labeler Name: | Watson Pharma, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076684 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120127 |
Package Information of Enoxaparin Sodium
| Package NDC: | 62037-864-20 |
| Package Description: | 10 BLISTER PACK in 1 CARTON (62037-864-20) > 1 SYRINGE in 1 BLISTER PACK > .8 mL in 1 SYRINGE |
NDC Information of Enoxaparin Sodium
| NDC Code | 62037-864-20 |
| Proprietary Name | Enoxaparin Sodium |
| Package Description | 10 BLISTER PACK in 1 CARTON (62037-864-20) > 1 SYRINGE in 1 BLISTER PACK > .8 mL in 1 SYRINGE |
| Product NDC | 62037-864 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Enoxaparin Sodium |
| Dosage Form Name | INJECTION |
| Route Name | SUBCUTANEOUS |
| Start Marketing Date | 20120127 |
| Marketing Category Name | ANDA |
| Labeler Name | Watson Pharma, Inc. |
| Substance Name | ENOXAPARIN SODIUM |
| Strength Number | 120 |
| Strength Unit | mg/.8mL |
| Pharmaceutical Classes | Heparin, Low-Molecular-Weight [Chemical/Ingredient],Low Molecular Weight Heparin [EPC] |
